Serial Number 98604886
Registration 7942300
700

Registration Progress

Application Filed
Jun 17, 2024
Under Examination
Mar 18, 2025
Approved for Publication
Jan 21, 2025
Published for Opposition
Jan 21, 2025
Registered
Sep 9, 2025

Trademark Image

Basic Information

Serial Number
98604886
Registration Number
7942300
Filing Date
June 17, 2024
Registration Date
September 9, 2025
Published for Opposition
January 21, 2025
Drawing Code
2

Status Summary

Current Status
Active
Status Code
700
Status Date
Sep 9, 2025
Registration
Registered
Classes
005

Rights Holder

Mirum Pharmaceuticals, Inc.

03
Address
989 E Hillsdale Blvd., Suite 300
Foster City, CA 94404

Ownership History

Mirum Pharmaceuticals, Inc.

Original Applicant
03
Foster City, CA

Mirum Pharmaceuticals, Inc.

Owner at Publication
03
Foster City, CA

Mirum Pharmaceuticals, Inc.

Original Registrant
03
Foster City, CA

Legal Representation

Attorney
Karl M. Zielaznicki, Esq.

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

25 events
Date Code Type Description Documents
Sep 9, 2025 NRCC E NOTICE OF REGISTRATION CONFIRMATION EMAILED Loading...
Sep 9, 2025 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Aug 19, 2025 SUNA E NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED Loading...
Aug 19, 2025 CNPR P ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED Loading...
Jul 31, 2025 AITU A CASE ASSIGNED TO INTENT TO USE PARALEGAL Loading...
Jul 31, 2025 SUPC I STATEMENT OF USE PROCESSING COMPLETE Loading...
Jul 30, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jul 30, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jul 30, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Apr 9, 2025 EISU I TEAS STATEMENT OF USE RECEIVED Loading...
Apr 9, 2025 IUAF S USE AMENDMENT FILED Loading...
Mar 18, 2025 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Jan 24, 2025 ARAA I ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED Loading...
Jan 24, 2025 COAR I TEAS CHANGE OF OWNER ADDRESS RECEIVED Loading...
Jan 24, 2025 TCCA I TEAS CHANGE OF CORRESPONDENCE RECEIVED Loading...
Jan 24, 2025 REAP I TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED Loading...
Jan 24, 2025 CHAN I APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED Loading...
Jan 21, 2025 PUBO A PUBLISHED FOR OPPOSITION Loading...
Jan 21, 2025 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 15, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Oct 25, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Oct 24, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 25, 2024 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Sep 25, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jun 17, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of metabolic disorders; pharmaceutical preparations for the treatment of metabolic disorders, namely, cerebrotendinous xanthomatosis (CTX)
First Use Anywhere: Apr 3, 2025
First Use in Commerce: Apr 3, 2025

Additional Information

Design Mark
The mark consists of three shaded lines of increasing lengths at a parallel slant, followed by a shaded, straight vertical line.
Color Claim
Color is not claimed as a feature of the mark.

Classification

International Classes
005